# |
Query |
Results |
S38 |
S23 AND S37 |
125 |
S37 |
S29 OR S30 OR S31 OR S32 OR S33 OR S34 OR S35 OR S36 |
1,188,882 |
S36 |
TX allocat* random* |
10,322 |
S35 |
(MH "Quantitative Studies") |
22,647 |
S34 |
(MH "Placebos") |
11,328 |
S33 |
TX placebo* |
57,156 |
S32 |
TX random* allocat* |
10,322 |
S31 |
(MH "Random Assignment") |
55,019 |
S30 |
TX randomi* control* trial* |
169,987 |
S29 |
TX ( (singl* n1 blind*) or (singl* n1 mask*) ) or TX ( (doubl* n1 blind*) or (doubl* n1 mask*) ) or TX ( (tripl* n1 blind*) or (tripl* n1 mask*) ) or TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
1,018,439 |
S28 |
TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
233 |
S27 |
TX ( (trebl* n1 blind*) or (trebl* n1 mask*) ) |
233 |
S26 |
TX clinic* n1 trial* |
245,100 |
S25 |
PT Clinical trial |
86,725 |
S24 |
(MH "Clinical Trials+") |
261,135 |
S23 |
S12 AND S22 |
541 |
S22 |
S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19 OR S20 OR S21 |
9,042 |
S21 |
TX intrauterine contraceptive device |
425 |
S20 |
(MM "Intrauterine Devices") OR "intrauterine devices" |
2,863 |
S19 |
TX medicated intrauterine device* |
7 |
S18 |
TX IUD |
1,328 |
S17 |
TX mirena |
117 |
S16 |
TX LNG |
433 |
S15 |
TX Levonorgestrel |
1,840 |
S14 |
(MM "Levonorgestrel") OR "Levonorgestrel" |
1,819 |
S13 |
(MH "Progestational Hormones+") |
4,799 |
S12 |
S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 |
34,939 |
S11 |
TX endometrial resection |
110 |
S10 |
TX hysterectom* |
9,908 |
S9 |
TX ablation |
23,660 |
S8 |
TX heavy period* |
258 |
S7 |
TX excessive menstrua* |
54 |
S6 |
TX hypermenorr* |
24 |
S5 |
TX (dysfunctional uterine bleeding) |
129 |
S4 |
TX abnormal uterine bleeding |
555 |
S3 |
TX heavy menstrua* |
484 |
S2 |
TX Menorrhagia |
1,319 |
S1 |
(MM "Menorrhagia") |
711 |